We are live on
!
Find out more
Two Sigma Investments Portfolio holdings
AUM
$124B
1-Year Est. Return
33.93%
This Fund
S&P 500
This Quarter
Est. Return
-0.88%
1 Year Est. Return
+33.93%
3 Year Est. Return
+96.56%
5 Year Est. Return
+105.93%
10 Year Est. Return
+538.88%
AUM
$33.9B
AUM Growth
-$12.9B
(-28%)
Cap. Flow
-$11.3B
Cap. Flow
% of AUM
-33.44%
Top 10 Holdings %
Top 10 Hldgs %
7.18%
Holding
4,846
New
656
Increased
881
Reduced
976
Closed
2,305
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$226M |
| 2 |
JPMorgan Chase
JPM
|
+$212M |
| 3 |
TSMC
TSM
|
+$204M |
| 4 |
Occidental Petroleum
OXY
|
+$194M |
| 5 |
Apple
AAPL
|
+$180M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$271M |
| 2 |
Microsoft
MSFT
|
+$267M |
| 3 |
Canadian Pacific Kansas City
CP
|
+$255M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$226M |
| 5 |
Coca-Cola
KO
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.43% |
| 2 | Healthcare | 14.66% |
| 3 | Industrials | 10.19% |
| 4 | Consumer Discretionary | 10.1% |
| 5 | Financials | 9.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2376
Montauk Renewables
MNTK
$243M
| $139K | ﹤0.01% |
+12,426
| New | +$130K |
|
2377
Cullinan Oncology
CGEM
$1.18B
| $138K | ﹤0.01% |
13,213
-2,913
| -18% | -$39.4K |
|
|
AIOS
2378
AIOS Tech
AIOS
$38.9M
| $138K | ﹤0.01% |
706
+579
| +456% | +$158K |
|
2379
Tantech Holdings
TANH
$6.18M
| $138K | ﹤0.01% |
+303
| New | +$713K |
|
2380
Gaia
GAIA
$48.1M
| $135K | ﹤0.01% |
27,373
-26,494
| -49% | -$181K |
|
2381
Stereotaxis
STXS
$143M
| $134K | ﹤0.01% |
35,939
-90,063
| -71% | -$425K |
|
|
PRTK
2382
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $133K | ﹤0.01% |
44,884
-26,029
| -37% | -$97.9K |
|
2383
Orion Energy Systems
OESX
$78.3M
| $131K | ﹤0.01% |
4,680
-20,150
| -81% | -$647K |
|
|
GRTS
2384
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $131K | ﹤0.01% |
+31,753
| New | +$168K |
|
|
SHCO
2385
DELISTED
Soho House & Co
SHCO
| $130K | ﹤0.01% |
+16,804
| New | +$148K |
|
|
BTTX
2386
DELISTED
Better Therapeutics, Inc. Common Stock
BTTX
| $130K | ﹤0.01% |
65,792
-58,957
| -47% | -$204K |
|
2387
Ardmore Shipping
ASC
$670M
| $129K | ﹤0.01% |
+28,726
| New | +$113K |
|
2388
Custom Truck One Source
CTOS
$2.42B
| $128K | ﹤0.01% |
15,200
-3,800
| -20% | -$30.7K |
|
|
VERO
2389
DELISTED
Venus Concept
VERO
| $128K | ﹤0.01% |
544
-761
| -58% | -$193K |
|
2390
Biodesix
BDSX
$262M
| $125K | ﹤0.01% |
3,684
+333
| +10% | +$21.8K |
|
2391
Burford Capital
BUR
$940M
| $125K | ﹤0.01% |
+13,614
| New | +$130K |
|
2392
DiaMedica Therapeutics
DMAC
$358M
| $125K | ﹤0.01% |
50,068
-90,789
| -64% | -$258K |
|
2393
TELA Bio
TELA
$41.6M
| $123K | ﹤0.01% |
10,548
-5,500
| -34% | -$66.6K |
|
2394
InfuSystem Holdings
INFU
$241M
| $122K | ﹤0.01% |
12,400
+100
| +0.8% | +$1.28K |
|
|
PRVB
2395
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $122K | ﹤0.01% |
+16,600
| New | +$99.3K |
|
|
IPHA
2396
Innate Pharma
IPHA
$208M
| $121K | ﹤0.01% |
36,089
-30,966
| -46% | -$114K |
|
|
WHLM
2397
DELISTED
Wilhelmina International, Inc
WHLM
| $120K | ﹤0.01% |
25,732
-17,671
| -41% | -$78.5K |
|
|
LJPC
2398
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $118K | ﹤0.01% |
27,544
-60,632
| -69% | -$264K |
|
2399
Traws Pharma
TRAW
$8.22M
| $117K | ﹤0.01% |
2,545
-169
| -6% | -$7.83K |
|
2400
Cognition Therapeutics
CGTX
$94M
| $116K | ﹤0.01% |
42,102
-41,296
| -50% | -$159K |
|
Similar funds
VAM
Two Sigma Investments's Q1 2022 Portfolio in Review
As of Q1 2022, Two Sigma Investments held 4,846 positions worth $33.9B, down 28% from $46.8B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.
Two Sigma Investments withdrew a net $11.3B in Q1 2022, closing 2,305 positions and reducing 976 holdings. Its most notable exit was Pfizer, an estimated $271M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Two Sigma Investments opened a new position in Cisco worth $223M.
- Two Sigma Investments's largest Q1 2022 buy was Cisco: 4,001,362 shares worth $223M.
- Two Sigma Investments added most to JPMorgan Chase in Q1 2022, an estimated $212M increase.
- Two Sigma Investments's biggest Q1 2022 reduction was Coca-Cola, cutting an estimated $225M.
- Two Sigma Investments fully exited Pfizer in Q1 2022, selling an estimated $271M.
- Two Sigma Investments's ten largest holdings make up 7.2% of its $33.9B portfolio in Q1 2022.
- Two Sigma Investments opened 656 new positions and closed 2,305 in Q1 2022.
- Two Sigma Investments's portfolio value fell 28% quarter-over-quarter to $33.9B.
Based on Two Sigma Investments's 13F filing for Q1 2022, filed 16 May 2022.